|
|
878
|
Cath Lab Digest - ISSN: 1073-2667 - Volume 16 - Issue 2 - February 2008 | |
|
|
| Questions are answered by:
Todd Ginapp, EMT-P, RCIS, FSICP |
A Q&A column for those new to the cath lab
|
DRUG-ELUTING STENT SOLUTIONS |
| Lowell F. Satler, MD |
This monthly column in Cath Lab Digest reviews important points of distinction in drug-eluting stents (DES), from characteristics to techniques, so that physicians have valuable and relevant information about this revolutionary technology.
|
Incidence and Predictors of Vascular Complications after Invasive Coronary Procedures: A Prospective Analysis |
| Neelima Penugonda, MD, Jennifer Jones, MD,
J. Richard Spears, MD, Theodore Schreiber, MD
Wayne State University, Detroit, Michigan |
Background. Although clinical trial data suggest that the incidence of hemorrhagic vascular complications associated with invasive coronary procedures is relatively low, contemporary data from tertiary care centers are lacking.
Objective. The purpose of the study was to determine the incidence and potential predictors of hemorrhagic vascular complications after invasive coronary procedures, either diagnostic alone (contrast angiography [CA]) or combined with an interventional procedure (percutaneous coronary intervention [PCI]).
Methods. Clinical characteristics and procedural data in 200 consecutive patients undergoing an invasive coronary procedure (CA = 124; PCI = 76) at a single large urban tertiary care center were collected prospectively during their hospital stay. Multivariate logistic regression methods (SAS v9.1) were used to identify independent predictors of hemorrhagic vascular complications.
Results. The overall incidence of hemorrhagic vascular complications was 10%
|
Excerpt from: Chapter 19. STEMI Interventions – Future Perspectives |
| Sameer Mehta, MD, FACC, MBA |
Dr. Mehta will be commenting on the important work going on around the world as societies and their hospitals struggle to educate patients about the importance of timely intervention in ST-elevation myocardial infarction, and work collaboratively to decrease the time from patient arrival to intervention.
This month, we share an excerpt from Dr. Mehta’s upcoming Textbook of STEMI Interventions.
|
Cath Lab Spotlight: Bay Regional Medical Center |
| Scott Fylling, RCIS, Cath Lab Manager, Willa Rousseau, BSN, Cath Lab Director, Bay City, Michigan. Interviewed by Karen DiDonato, RN, MSN, Abbott Vascular, Redwood City, California |
|
|
A 3D CT Vessel “Roadmap” Over Live Fluoroscopy for Chronic Total Occlusion |
| Cath Lab Digest talks with Jeffrey W. Moses, MD |
During a live case at TCT 2007, Dr. Jeffrey Moses demonstrated a unique new technology currently under development by GE Healthcare, (Chalfont St Giles, United Kingdom). Using a next-generation GE Advantage Windows workstation, a patient’s prior cardiac computed tomography angiography (CTA) images can be superimposed on live fluoroscopy as a “roadmap” for guidewire advancement, chronic total occlusion (CTO) crossing and therapy delivery. Dr. Moses discusses the increasing use of CTA, the treatment of CTOs and his thoughts on where this technology is headed.
|
|
|
| For more information about the SICP at New Cardiovascular Horizons, see: Powell D. The Society of Invasive Cardiovascular Professionals Holds an RCIS Review Course at New Cardiovascular Horizons. Cath Lab Digest Jan 2008;16(1):43-44 |
|
|
|
|
|
|
|
|
|
|
|
The 2005 Cath Lab Digest Salary Survey
|
Cath Lab Digest conducted its fifth annual salary survey in an attempt to
assess the market value of cardiac catheterization laboratory professionals
across the country. The survey will also be available on our website,
www.cathlabdigest.com, as a PDF file. Cath Lab Digest had 108 survey responses.
Click here to learn more |
|
|
On Demand Medical Education
|
|
|
|
|
